Literature DB >> 16501248

Genetic variants in epigenetic genes and breast cancer risk.

Arancha Cebrian1, Paul D Pharoah, Shahana Ahmed, Santiago Ropero, Mario F Fraga, Paula L Smith, Don Conroy, Robert Luben, Barbara Perkins, Douglas F Easton, Alison M Dunning, Manel Esteller, Bruce A J Ponder.   

Abstract

Epigenetic events, resulting changes in gene expression capacity, are important in tumour progression, and variation in genes involved in epigenetic mechanisms might therefore be important in cancer susceptibility. To evaluate this hypothesis, we examined common variants in 12 genes coding for DNA methyltransferases (DNMT), histone acetyltransferases, histone deacetyltransferases, histone methyltrasferases and methyl-CpG binding domain proteins, for association with breast cancer in a large case-control study (N cases = 4474 and N controls = 4580). We identified 63 single nucleotide polymorphisms (SNPs) that efficiently tag all the known common variants in these genes, and are also expected to tag any unknown SNP in each gene. We found some evidence for association for six SNPs: DNMT3b-c31721t [P (2 df) = 0.007], PRDM2-c99243 t [P (2 df) = 0.03] and t105413c [P-recessive = 0.05], EHMT1-g-9441a [P (2df) = 0.05] and g41451t (P-trend = 0.04), and EHMT2-S237S [P (2df) = 0.04]. The most significant result was for DNMT3b-c31721t (P-trend = 0.124 after adjusting for multiple testing). However, there were three other results with P < 0.05. The permutation-based probability of this occurring by chance was 0.335. These significant SNPs were genotyped in 75 human cancer cell lines from different tumour types to assess if there was an association between them and six epigenetic measures. No statistically significant association was found. However, a trend was observed: homozygotes for the rare alleles of the EHMT1, EHMT2 and PRDM2 had a mean value for both trimethylation of K9 and K27 of histone H3 remarkably different to the homozygotes for the common alleles. Thus, these preliminary observations suggest the possible existence of a functional consequence of harbouring these genetic variants in histone methyltransferases, and warrant the design of larger epidemiological and biochemical studies to establish the true meaning of these findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501248     DOI: 10.1093/carcin/bgi375

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  34 in total

1.  Sialidosis type I with neoplasms in siblings: the first clinical cases.

Authors:  Yohsuke Yagi; Akira Machida; Shuta Toru; Takayoshi Kobayashi; Toshiki Uchihara
Journal:  Neurol Sci       Date:  2010-08-13       Impact factor: 3.307

2.  Association of multi-pathogenic infections with BAT2, CXCL12, Mx1 and EHMT2 variations in pigs.

Authors:  S J Wang; W J Liu; L G Yang; H B Liu; C A Sargent; N A Affara; S J Zhang
Journal:  Mol Biol Rep       Date:  2012-04-25       Impact factor: 2.316

Review 3.  Prospects for epigenetic epidemiology.

Authors:  Debra L Foley; Jeffrey M Craig; Ruth Morley; Craig A Olsson; Craig J Olsson; Terence Dwyer; Katherine Smith; Richard Saffery
Journal:  Am J Epidemiol       Date:  2009-01-12       Impact factor: 4.897

4.  Euchromatic histone lysine methyltransferase 1 regulates cancer development in human gastric cancer by regulating E-cadherin.

Authors:  Yao Yang; Jianfeng Shen; Dongyi Yan; Biao Yuan; Shun Zhang; Jing Wei; Tao Du
Journal:  Oncol Lett       Date:  2018-04-16       Impact factor: 2.967

5.  The DNMT3B -579 G>T promoter polymorphism and risk of lung cancer.

Authors:  Hui Liu; Yifei Jiao; Yana Guan; Yingbin Lao; Chengcheng Zhao; Hong Fan
Journal:  Exp Ther Med       Date:  2011-12-19       Impact factor: 2.447

Review 6.  Epigenetic research in cancer epidemiology: trends, opportunities, and challenges.

Authors:  Mukesh Verma; Scott Rogers; Rao L Divi; Sheri D Schully; Stefanie Nelson; L Joseph Su; Sharon A Ross; Susan Pilch; Deborah M Winn; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-12-10       Impact factor: 4.254

7.  Genetic variation in the one-carbon transfer pathway and ovarian cancer risk.

Authors:  Linda E Kelemen; Thomas A Sellers; Joellen M Schildkraut; Julie M Cunningham; Robert A Vierkant; V Shane Pankratz; Zachary S Fredericksen; Madhura K Gadre; David N Rider; Mark Liebow; Ellen L Goode
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

8.  Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients.

Authors:  Marjanka K Schmidt; Johanna Tommiska; Annegien Broeks; Flora E van Leeuwen; Laura J Van't Veer; Paul D P Pharoah; Douglas F Easton; Mitul Shah; Manjeet Humphreys; Thilo Dörk; Scarlett A Reincke; Rainer Fagerholm; Carl Blomqvist; Heli Nevanlinna
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

9.  Human intelligence and polymorphisms in the DNA methyltransferase genes involved in epigenetic marking.

Authors:  Paul Haggarty; Gwen Hoad; Sarah E Harris; John M Starr; Helen C Fox; Ian J Deary; Lawrence J Whalley
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

Review 10.  Breast cancer epigenetics: from DNA methylation to microRNAs.

Authors:  Jürgen Veeck; Manel Esteller
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-01-27       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.